MALT1 是一种副胱天蛋白酶,它与胱天蛋白酶(半胱氨酸-天冬氨酸蛋白酶)蛋白酶家族有关,但在 Arg 残基而不是 Asp 后进行切割。MALT1 切割活性与活化 B 细胞样弥漫大 B 细胞淋巴瘤 (ABC-DLBCL) 的发病机制有关,ABC-DLBCL 是一种化学耐药形式的 DLBCL。MALT1 是一种独特的副胱天蛋白酶蛋白,可在 ABC-DLBCL 中传导异常的致癌信号。MALT1 是 ABC-DLBCL 和 MALT 淋巴瘤的潜在重要治疗靶点。MALT1 小分子抑制剂可能是研究 MALT1 生物学和治疗 MALT1 成瘾肿瘤的有用化学工具。
MALT1 is a paracaspase, which is related to the caspase (cysteine-aspartic proteases) family of proteases but cleaves after Arg residues instead of Asp. MALT1 cleavage activity is linked to the pathogenesis of activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL), a chemoresistant form of DLBCL. MALT1 is a unique paracaspase protein that transduces aberrant oncogenic signaling in ABC-DLBCL. MALT1 represents a potentially important therapeutic target for ABC-DLBCL and MALT lymphoma. MALT1 small molecule inhibitors might be useful chemical tools for studying MALT1 biology and treating MALT1-addicted tumors.
PROTAC MALT1 Degrader-1(Compound 176)是一种MALT1 PROTAC降解剂,可用于淋巴瘤研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号